Yatin Suneja
Stock Analyst at Guggenheim
(4.82)
# 101
Out of 5,241 analysts
178
Total ratings
64.81%
Success rate
32.81%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMS Alumis | Maintains: Buy | $32 → $34 | $21.15 | +60.76% | 4 | May 15, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,120 → $1,135 | $776.26 | +46.21% | 15 | May 8, 2026 | |
| NBIX Neurocrine Biosciences | Reiterates: Buy | $175 | $157.21 | +11.32% | 7 | May 6, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $245 → $260 | $227.40 | +14.34% | 12 | May 5, 2026 | |
| DBVT DBV Technologies | Reiterates: Buy | $51 | $18.71 | +172.58% | 4 | May 4, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $975 → $995 | $629.68 | +58.02% | 10 | May 1, 2026 | |
| BIIB Biogen | Maintains: Buy | $246 → $260 | $191.91 | +35.48% | 5 | Apr 30, 2026 | |
| IFRX InflaRx | Reiterates: Buy | $14 | $2.50 | +460.00% | 8 | Apr 21, 2026 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $125 | $58.34 | +114.26% | 5 | Apr 13, 2026 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $14 | $1.77 | +690.96% | 4 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.29 | +386.32% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $11.66 | +500.34% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $55 | $16.91 | +225.25% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $128 → $100 | $7.50 | +1,233.33% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $200 | $83.60 | +139.23% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $39.24 | +27.42% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $25 | $11.39 | +119.49% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $760 → $800 | $320.53 | +149.59% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $28.55 | +5.08% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $26.53 | +65.85% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $16.16 | +209.41% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.56 | +321.35% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $58.74 | +70.24% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $113.55 | +32.10% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $16.44 | +21.65% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $21.13 | +254.95% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.24 | +702.47% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $21.68 | +33.76% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.12 | +264.08% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $27.67 | +62.63% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $20.69 | -3.33% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.75 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $70.08 | -7.25% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $30.22 | +197.82% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.13 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $53.71 | -8.77% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $11.70 | +370.09% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.34 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $16.11 | +48.98% | 1 | May 31, 2022 |
Alumis
May 15, 2026
Maintains: Buy
Price Target: $32 → $34
Current: $21.15
Upside: +60.76%
argenx SE
May 8, 2026
Maintains: Buy
Price Target: $1,120 → $1,135
Current: $776.26
Upside: +46.21%
Neurocrine Biosciences
May 6, 2026
Reiterates: Buy
Price Target: $175
Current: $157.21
Upside: +11.32%
Axsome Therapeutics
May 5, 2026
Maintains: Buy
Price Target: $245 → $260
Current: $227.40
Upside: +14.34%
DBV Technologies
May 4, 2026
Reiterates: Buy
Price Target: $51
Current: $18.71
Upside: +172.58%
Regeneron Pharmaceuticals
May 1, 2026
Maintains: Buy
Price Target: $975 → $995
Current: $629.68
Upside: +58.02%
Biogen
Apr 30, 2026
Maintains: Buy
Price Target: $246 → $260
Current: $191.91
Upside: +35.48%
InflaRx
Apr 21, 2026
Reiterates: Buy
Price Target: $14
Current: $2.50
Upside: +460.00%
Oruka Therapeutics
Apr 13, 2026
Reiterates: Buy
Price Target: $125
Current: $58.34
Upside: +114.26%
Neumora Therapeutics
Mar 31, 2026
Reiterates: Buy
Price Target: $14
Current: $1.77
Upside: +690.96%
Mar 24, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $3.29
Upside: +386.32%
Mar 24, 2026
Initiates: Buy
Price Target: $70
Current: $11.66
Upside: +500.34%
Mar 17, 2026
Maintains: Buy
Price Target: $45 → $55
Current: $16.91
Upside: +225.25%
Mar 13, 2026
Maintains: Buy
Price Target: $128 → $100
Current: $7.50
Upside: +1,233.33%
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $83.60
Upside: +139.23%
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $39.24
Upside: +27.42%
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.39
Upside: +119.49%
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $320.53
Upside: +149.59%
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $28.55
Upside: +5.08%
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $26.53
Upside: +65.85%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $16.16
Upside: +209.41%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.56
Upside: +321.35%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $58.74
Upside: +70.24%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $113.55
Upside: +32.10%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $16.44
Upside: +21.65%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $21.13
Upside: +254.95%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.24
Upside: +702.47%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $21.68
Upside: +33.76%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $27.67
Upside: +62.63%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $20.69
Upside: -3.33%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.75
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $70.08
Upside: -7.25%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $30.22
Upside: +197.82%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $53.71
Upside: -8.77%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $11.70
Upside: +370.09%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.34
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $16.11
Upside: +48.98%